Evidence map›Paper›PMID 10569758›Full record

ArticleInfection and immunity1999

Involvement of protein kinase C in Rickettsia rickettsii-induced transcriptional activation of the host endothelial cell.

S K Sahni, L C Turpin, T L Brown, L A Sporn

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. AnJournal of biosciences · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

S K SahniVascular Medicine Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA. Sanjeev_sahni@urmc.rochester.edu
L C Turpin
T L Brown
L A Sporn
Center for Vascular Biology Research · USUniversity of Rochester · US

Funding

VON WILLEBRAND PROTEIN BIOSYNTHESIS AND STRUCTUREP01HL030616 · NHLBI · UNIVERSITY OF ROCHESTER · PI FRANCIS, CHARLES W. · 1985 to 2003
$6.5M
RICKETTSIA-INDUCED TRANSCRIPTIONAL ACTIVATIONR01AI040689 · NIAID · UNIVERSITY OF ROCHESTER · PI SAHNI, SANJEEV K. · 1997 to 2007
$2.0M
RICKETTSIA RICKETTSII IN HUMAN ENDOTHELIAL CELLSR01AI017416 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI SILVERMAN, DAVID J · 1986 to 2002
$1.0M
Rickettsia-Induced Transcriptional ActivationR21AI040689 · NIAID · UNIVERSITY OF ROCHESTER · PI SAHNI, SANJEEV · 2002 to 2002
$347k
NHLBI NIH HHS HL30616NIAID NIH HHS AI17416NIAID NIH HHS AI40689NIAID NIH HHS R01 AI040689NIAID NIH HHS R21 AI040689
6 · The paper itself

Abstract

Our laboratory has reported on a biphasic pattern of nuclear factor kappaB (NF-kappaB) activation in cultured human umbilical vein endothelial cells during infection with Rickettsia rickettsii, an obligate, intracellular bacterium, and the etiologic agent of Rocky Mountain spotted fever. Transcriptional activation of the tissue factor (TF) gene during this infection has been shown to involve NF-kappaB. To further understand the signal transduction events underlying these phenomena, we studied the role of protein kinase C (PKC), a ubiquitous family of phospholipid-dependent enzymes implicated in the regulation of a variety of cell signaling pathways. Two inhibitors of PKC, namely, bisindolylmaleimide I hydrochloride (BM-1) and calphostin C, which exhibit different inhibitory properties towards various isozymes of PKC, were used. Infection of cells with R. rickettsii in the presence of BM-1 (50 nM) did not significantly affect NF-kappaB, whereas calphostin C (2.5 microM) completely blocked the early phase of NF-kappaB activation. The late, sustained phase also was not affected by treatment with BM-1. Downregulation of phorbol ester-sensitive PKCs by long-term treatment with phorbol 12-myristate 13-acetate (PMA) did not inhibit NF-kappaB activation. Likewise, this downregulation had no effect on induction of TF activity. The activity of TF was, however, sensitive to BM-1 and calphostin C, whereas expression of TF mRNA was inhibited only by calphostin C. Overall, these results suggest the lack of involvement of classical PKC pathways in R. rickettsii-induced NF-kappaB activation but the possible involvement of a non-PMA-responsive PKC isoform in the posttranscriptional control of TF expression.

Indexed as

Transcriptional ActivationCells, CulturedEndothelium, VascularEnzyme InhibitorsHumansNaphthalenesNF-kappa BProtein Kinase CProteinsReverse Transcriptase Polymerase Chain ReactionRickettsia rickettsiiSignal TransductionTetradecanoylphorbol AcetateThromboplastinUmbilical VeinsBM-1, platelet aggregation inhibitorcalphostin CEnzyme InhibitorsNaphthalenesNF-kappa BProtein Kinase CProteinsTetradecanoylphorbol AcetateThromboplastin

Identifiers

PMID10569758
PMCPMC97050
OpenAlexW2170430687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.